Market Tracker

07/25 6:05pm ET

Theravance Inc (NASDAQ:THRX)

During the Trading Day
22.94 -0.94 / -3.94%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
22.94 0.00 / 0.00%
 
Volume: 14.2K

Today’s Trading

Previous close23.88
Today’s open23.37
Day’s range22.51 - 23.80
Volume1,532,947
Average volume (3 months)1,241,344
Market cap$2.7B
Dividend yield--
Data as of 4:00pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+29.22%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book8.90

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc-0.33-0.88%
WXWuXi Pharmatech (Cay...-0.04-0.12%
NPSPNPS Pharmaceuticals ...-0.07-0.24%
IRWDIronwood Pharmaceuti...-0.04-0.26%
Data as of 4:04pm ET, 07/25/2014

Financials

Last reporting dateJuly 24, 2014
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts